Form4insider filings, from the source

SEC Form 3 · accession 0000903423-19-000015

Urovant Sciences Ltd. · UROV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jan 1, 2019
Accepted (ET)
Jan 10, 2019 · 4:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001740547

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Shares, $0.000037453 par value per shareF1,F2,F3,F4holding———22,703,669ISee Explanation of Responses

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

(5) Each of O. Andreas Halvorsen, David C. Ott and Rose S. Shabet is signing as an Executive Committee Member of VIKING GLOBAL PERFORMANCE LLC, on behalf of VIKING GLOBAL EQUITIES MASTER LTD.